<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>In vivo fates of degradable poly(ß-malic acid)and of its precursor, malic acid</title>
  </titleInfo>
  <name type="personal">
    <namePart>Domurado, D.</namePart>
  </name>
  <name type="personal">
    <namePart>Fournié, P.</namePart>
  </name>
  <name type="personal">
    <namePart>Braud, C.</namePart>
  </name>
  <name type="personal">
    <namePart>Vert, M.</namePart>
  </name>
  <name type="personal">
    <namePart>Guérin, P.</namePart>
  </name>
  <name type="personal">
    <namePart>Simonnet, F.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xx</placeTerm>
    </place>
    <dateIssued encoding="marc">9999</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">und</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
  </physicalDescription>
  <abstract>To determine whether degradation could influence the in vivo elimination pattern of poly(ß-malic acid)in mice, radioactive urinary excretion and 14CO2 expiration were studied after intravenous injection of 14C-radiolabeled poly(ß-malic acid)and of its precursor, 14C-malate. The precursor administration led to rapid 14CO2 exhalation, and only negligible urinary elimination. The reverse was observed for the polymer. It was concluded that: (i)the in vivo degradation of poly(ß-malic acid)chains, if any during the 24-h period of the study, did not release detectable malate molecules, (ii)the large urinary excretion of poly(ß-malic acid)was due to the molar masses being less than the renal filtration threshold, (iii)the degradation of the poly(ß-malic acid)chains in blood was slow enough to allow the fraction with higher molar masses to enter the interstitial space of the tissues, and possibly cells.</abstract>
  <subject>
    <topic>CO2 EXPIRATION</topic>
  </subject>
  <subject>
    <topic>BIODEGRADABLE POLYMER</topic>
  </subject>
  <subject>
    <topic>IN VIVO FATE</topic>
  </subject>
  <subject>
    <topic>PHARMACOKINETICS</topic>
  </subject>
  <subject>
    <topic>RADIOACTIVE FOLLOW-UP</topic>
  </subject>
  <subject>
    <topic>URINARY EXCRETION</topic>
  </subject>
  <relatedItem type="series">
    <titleInfo>
      <title>Journal of Bioactive and Compatible Polymers, 18(1), p.23-32, 2003</title>
    </titleInfo>
  </relatedItem>
  <identifier type="uri">https://drive.google.com/file/d/1VwlRwAhqWTkrs4ANwkKpWGWT8qjeSHei/view?usp=drivesdk</identifier>
  <location>
    <url>https://drive.google.com/file/d/1VwlRwAhqWTkrs4ANwkKpWGWT8qjeSHei/view?usp=drivesdk</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg"/>
    <recordCreationDate encoding="marc">250602</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260521091508.0</recordChangeDate>
  </recordInfo>
</mods>
